RBp050 for acute inflammatory conditions

Our peptide RAGE inhibitor, RBp050, is at the research stage as a potential drug for acute inflammatory conditions featuring excessive RAGE signalling.

​

Our peptide drugs block pro-inflammatory signalling from activated RAGE in inflamed tissue.